StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.98+0.04 (+2.06%)

Close on Nov 12, 2026Market cap $78.11MP/E –Yield –

Sera Prognostics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Sera Prognostics's ebitda for the twelve months ending Sep 30, 2026 was -$36.41M. For fiscal 2025 it was -$35.56M. The highest annual figure on record is -$17.08M in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.56M–
FY2024Dec 31, 2024-$35.80M–
FY2023Dec 31, 2023-$38.92M–
FY2022Dec 31, 2022-$44.90M–
FY2021Dec 31, 2021-$34.74M–
FY2020Dec 31, 2020-$17.08M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$8.70M–
Q2 FY2026Jun 30, 2026-$9.84M–
Q1 FY2026Mar 31, 2026-$9.17M–
Q4 FY2025Dec 31, 2025-$8.71M–
Q3 FY2025Sep 30, 2025-$8.77M–
Q2 FY2025Jun 30, 2025-$9.11M–
Q1 FY2025Mar 31, 2025-$9.03M–
Q4 FY2024Dec 31, 2024-$9.21M–
Q3 FY2024Sep 30, 2024-$8.66M–
Q2 FY2024Jun 30, 2024-$9.05M–
Q1 FY2024Mar 31, 2024-$8.88M–
Q4 FY2023Dec 31, 2023-$8.64M–
Q3 FY2023Sep 30, 2023-$7.98M–
Q2 FY2023Jun 30, 2023-$11.26M–
Q1 FY2023Mar 31, 2023-$11.09M–
Q4 FY2022Dec 31, 2022-$10.22M–
Q3 FY2022Sep 30, 2022-$10.99M–
Q2 FY2022Jun 30, 2022-$11.55M–
Q1 FY2022Mar 31, 2022-$12.14M–
Q4 FY2021Dec 31, 2021-$12.40M–
Q3 FY2021Sep 30, 2021-$9.34M–
Q2 FY2021Jun 30, 2021-$7.18M–
Q1 FY2021Mar 31, 2021-$5.82M–
Q4 FY2020Dec 31, 2020-$4.55M–
Q3 FY2020Sep 30, 2020-$4.44M–
Q2 FY2020Jun 30, 2020-$4.08M–

More Sera Prognostics figures

See a number that looks wrong?